<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2696</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">http://dx.doi.org/10.31782/IJCRR.2020.12132</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Influence of Basic Fibroblast Growth Factor on Biological and Phenotypic Properties of Human Bone Marrow Mesenchymal Stem Cells&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nitilapura</surname><given-names>Narendra</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rao</surname><given-names>Shama</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shetty</surname><given-names>Siddharth M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Arumugam</surname><given-names>Meenakshi</given-names></name></contrib><contrib contrib-type="author"><name><surname>A.</surname><given-names>Veena Shetty</given-names></name></contrib><contrib contrib-type="author"><name><surname>B.</surname><given-names>Mohana Kumar</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>6</day><month>07</month><year>2020</year></pub-date><volume>3)</volume><issue/><fpage>6</fpage><lpage>12</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Background: Bone marrow-derived mesenchymal stem cells (BMSCs) are ideal candidates for cell-based therapy due to their self-renewal and multilineage differentiation ability. During in vitro expansion, BMSCs tend to lose their proliferation rate and multipotency limiting their clinical use. Hence, supplementation of basic fibroblast growth factor (bFGF) during in vitro culture might positively influence the biological and phenotypic properties of expanded BMSCs.&#13;
Aim: This study was aimed to evaluate the supplementation of bFGF on selected biological and phenotypic characteristics of BMSCs.&#13;
Methods: Plastic-adherent BMSCs were cultured without (0 ng/mL) and with (5 ng/mL and 10 ng/mL) bFGF up to five passages and analyzed for their morphology, viability, proliferation rate, population doubling time (PDT), colony forming unit-fibroblast (CFU-F) assay, senescence activity, genetic stability and cell surface marker expression.&#13;
Results: BMSCSs exhibited a small, spindle-shape morphology in bFGF supplemented groups as compared to elongated fibroblast-like cells in control. No significant difference in viability and PDT was observed. However, noticeable differences were observed in proliferation rate and CFU-F ability between bFGF supplemented group and control. Further, the senescence activity of BMSCs was considerably decreased under the influence of bFGF. BMSCs had a normal karyotypein both bFGF supplemented and control groups. Lastly, addition of bFGF in expansion media slightly modified the phenotypic markers expression in BMSCs, corresponding to the concentrations used.&#13;
Conclusion: Supplementation of BFGFat10 ng/mL could be considered as an optimal and efficient concentration for expanding BMSCs in culture before their use in cell-based therapy.&#13;
</p></abstract><kwd-group><kwd>Basic fibroblast growth factor</kwd><kwd> Bone marrow mesenchymal stem cells</kwd><kwd> Human</kwd><kwd> In vitro</kwd><kwd> Markers expression</kwd></kwd-group></article-meta></front></article>
